Robert Califf, FDA commissioner (Photo by Drew Angerer/Getty Images)
March 28, 2023 02:21 PM EDTUpdated 03:32 PM
Pharma
FDA+
Manufacturing

House com­mit­tee to in­ves­ti­gate FDA's re­sponse to on­go­ing drug short­ages

Tyler Patchen

News Reporter

Re­pub­li­can lead­ers of the House Com­mit­tee on En­er­gy & Com­merce sent a five-page let­ter yes­ter­day an­nounc­ing an in­ves­ti­ga­tion in­to the on­go­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

No­vo Nordisk’s once-dai­ly he­mo­phil­ia drug Al­he­mo ap­proved in US

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

GSK's Ze­ju­la-Jem­per­li com­bo in ovar­i­an can­cer hits pri­ma­ry end­point, miss­es on over­all sur­vival

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

A service from the Financial Times